Kolexia
Da Silva Angelique Oncologie médicale
Da Silva Angelique
Oncologie médicale
Centre François-Baclesse
Caen, France
66 Activités
196 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs embryonnaires et germinales Fibrillation auriculaire Sclérose en plaques Hypertension artérielle Tumeurs du sein triple-négatives Tumeurs des glandes endocrines Pancytopénie Atteinte rénale aigüe

Collaborateurs

Voir plus
Villemin Maud
Villemin Maud
Cabinet libéral, Caen, France
Cherifi François
Cherifi François
Centre François-Baclesse, Caen, France
Boscher Clemence
Boscher Clemence
Centre François-Baclesse, Caen, France
Segura-Djezzar Carine
Segura-Djezzar Carine
Centre François-Baclesse, Caen, France

Industries

Voir plus
Leo Pharma
4 collaboration(s)
Dernière en 2022
MSD
4 collaboration(s)
Dernière en 2023
Daiichi Sankyo
3 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Multiple sclerosis (Houndmills, Basingstoke, England)   15 février 2024
Arterial hypertension associated with PARPi: A meta-analysis of 41 placebo randomized controlled trials combined with a World Health Organization's pharmacovigilance study.
Fundamental & clinical pharmacology   25 janvier 2024
Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer.
Expert opinion on drug metabolism & toxicology   12 janvier 2024
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's database.
Frontiers in pharmacology   20 octobre 2023
Infections associated with clozapine: a pharmacovigilance study using VigiBase .
Frontiers in pharmacology   02 octobre 2023
Does COVID-19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital.
Cancer medicine   26 juillet 2023
Pharmacovigilance contribution in an onco-cardio-pharmacology multidisciplinary team meeting
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
112P Correlation between HER2-negative status and risk of recurrence according to PAM50 score
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials.
JACC. CardioOncology   28 mars 2023
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.
Frontiers in oncology   19 janvier 2023